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The human hair follicle is a unique mini-organ, capable of life-long cycles of massive growth (anagen),
regression (catagen), and resting (telogen). Recent work has identified complex, stringently localized signaling
mechanisms between skin neuro-ectoderm and mesoderm that drive these cyclic organ transformations (hair
cycle). Pilosebaceous units have recently surfaced as both prominent targets and sources of prototypic stress
mediators. This presentation discusses these recent findings and their possible role in the control of the hair
cycle and melanogenesis.
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INTRODUCTION
The human hair follicle (HF) is a unique miniorgan, capable
of life-long cycles of massive growth (anagen), which
are followed by rapid, apoptosis-driven organ involution
(catagen) and periods of relative quiescence (telogen), and
interspersed with a phase of active hair shaft shedding
(exogen). Recent work has identified complex, stringently
localized signaling mechanisms between skin neuro-ectoderm
and mesoderm that drive these cyclic organ transformations
(hair cycle). An elusive intrafollicular biological clock
mechanism (hair cycle clock) regulates this process, which
may be located in the specialized inductive fibroblasts of the
dermal papilla, and results in defined switches of the intra-
and perifollicular signaling milieu of important growth factors
such as transforming growth factor-b, IGF-1, nerve growth
factor, and vascular endothelial growth factor, as well as of a
multitude of locally generated (neuro-)hormones, neuropep-
tides and other mediators. The basic autonomy of the hair
cycle clock is evident, for example, from the fact that even
single isolated human hair bulbs spontaneously undergo an
anagen-catagen transformation in vitro.
‘‘STRESS’’ AND THE HF
Like few other organs, the skin and its appendages are
continuously exposed to numerous exogenous, endogenous,
and psychological stressors, which affect its physiology and
pathology. Intriguingly, skin and its pilosebaceous units have
recently surfaced as both prominent targets of prototypic stress
mediators (such as corticotropin-releasing hormone, ACTH,
cortisol, catecholamines, prolactin (PRL), substance P, and nerve
growth factor) and as potent sources of these key mediators of
systemic stress responses. In fact, it has become clear that the
skin – and, again most prominently, the HF (including human
scalp HFs!) – has established primitive, but fully functional
peripheral equivalents of the hypothalamic–pituitary–adrenal axis
as independent, local stress response systems.
To cope with the key biochemical and biophysical
stressor, oxidative damage, HFs also express a number of
highly effective free-radical scavenging and DNA-repair
enzyme systems. This is complemented by the intrafollicular
synthesis of melatonin, the key hormone of the pineal gland
and probably the most potent antioxidant among all the
neurohormones produced by the mammalian body. Distur-
bances in the slowly unfolding ‘‘brain–skin connection’’, into
which the HF is fully integrated on multiple levels, may
underlie inflammatory skin diseases that are triggered or
aggravated by stress.
The HF ranks among the most exciting current research
frontiers in skin, hair, and stress biology as well as in
cutaneous neuroimmunology. The drive is to determine how
central stress response axes are linked and interact with local,
intrafollicular stress response systems. To study exemplarily
in the HFs of mice and men, the cross talk between peripheral
and systemic responses to psychological and oxidative stress
has already helped greatly to identify promising molecular
targets for therapeutic stress intervention. This may revolu-
tionize our approach to the treatment of skin diseases by the
targeted pharmacological or biophysical manipulation of
intracutaneous neuroendocrine regulatory loops.
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MELANOCORTINS
The melanocortin (MC) system is probably the best-char-
acterized neuropeptide network of the skin. Many cutaneous
cell types not only express MC receptors but also synthesize
MCs, such as a-melanocyte-stimulating hormone or ACTH
that act in an autocrine and paracrine manner. In human
skin cells, activation of adenylate cyclase by MCs occurs at
106 h. Besides the long-recognized pigmentary action of
MCs on epidermal melanocytes, multiple additional regula-
tory functions of MCs in skin biology (including e.g.,
immunomodulation, local stress responses, lipogenesis, con-
nective tissue turnover, cytoprotection etc.) have recently
become appreciated.
Given that the HF is a potent source and major target for
MC bioregulation, one key frontier in neuroendocrine hair
research is to characterize the specific, non-pigmentary
functions of intrafollicularly generated MCs in pilosebaceous
biology and pathology (e.g. maintenance and restoration of
HF immune privilege, regulation of sebum production,
stimulation of local glucocorticoid synthesis, cytoprotection
against UVB-induced apoptosis and DNA damage). Better
definition of these – as yet, largely obscure – functions and
their regulation by key-upstream regulators of MC production
(i.e., corticotropin-releasing hormone, which is not only the
chief hypothalamic ‘‘stress hormone’’ but also produced, e.g.,
by human scalp HFs!) should improve our understanding of
skin physiology and pathophysiology and is likely to invite
novel strategies for the management of hair growth disorders
that target intrafollicular MC production and MC receptor
expression.
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PROLACTIN
PRL is another key pituitary hormone PRL, which – like ACTH
– is prominently upregulated during stress responses. PRL
exerts a wide variety of non-mammatropic bioregulatory
effects in mammals and is also found in extrapituitary sites.
As shown by reverse transcriptase-PCR and immuno-
histology, human skin and normal human scalp HFs, in
particular, express both PRL and PRL receptors at the mRNA
and protein level. During the anagen–catagen transformation,
PRL and PRL receptors immunoreactivity appears upregu-
lated in human scalp HFs. Treatment of organ-cultured
human scalp HFs with high-dose PRL results in a signi-
ficant inhibition of hair shaft elongation and in premature
catagen development, along with reduced proliferation and
increased apoptosis of hair bulb keratinocytes. This shows
that human skin and human scalp HFs are both direct targets
and sources of PRL and suggests that PRL acts as an autocrine
hair growth modulator with catagen-promoting functions.
These new findings may help to understand the as yet
ill-explained hair loss in patients with hyperprolactinemia,
and may be exploited for treating, for example, unwanted
hair growth.
Recommended reading
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SEX STEROIDS: BEYOND THE ANDROGEN HORIZON
Last but not least, another frontier in (neuro-)endocrine hair
growth controls is that our concepts on the relevant classical
endocrine controls of hair growth are becoming much more
comprehensive by the steadily increasing recognition that
other sex steroids besides androgens deserve very careful
scrutiny. Evidently, androgens have long dominated endo-
crine research in hair growth control, and dihydrotesto-
sterone synthesis and the androgen receptor are key targets
for systemic, pharmacological hair growth control in clinical
medicine. However, it has equally long been known that
estrogens can alter HF growth and cycling profoundly by
binding to locally expressed high-affinity estrogen receptors
(ERs).
The recent renaissance of estrogen research in hair
research reflects the (re-)discovery that the HF offers an
ideal, clinically relevant test system for studying the role of
sex steroids, their receptors, and interactions in neuroecto-
dermal–mesodermal interaction systems in general. In addi-
tion, it can be exploited to identify novel functions and
signaling cross talks of ER-mediated signaling. Besides
altering the transcription of genes with estrogen-responsive
elements, 17b-estradiol also modifies androgen metabolism
within distinct subunits of the pilosebaceous unit (i.e., HF
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and sebaceous gland). The latter displays prominent
aromatase activity, the key enzyme for androgen conversion
to 17b-estradiol, and is, thus, both an estrogen source and
target.
However, the – often underestimated – complexity of
ER-dependent and ER-independent signaling events as
well as the species-, gender-, and site-dependency of
17b-estradiol-induced effects on the HF make it a truly
formidable task to dissect the most promising targets for
clinically relevant pharmacological intervention to mani-
pulate HF cycling by targeting ER and associated signa-
ling systems, ranging from androgenetic alopecia and
hirsutism via telogen effluvium to chemotherapy-induced
alopecia.
This complexity has further increased by recent evidence
that points towards glucocorticoid-dependent mechanisms,
which may operate in the ‘‘mesenchymal command center’’
of HFs, the dermal papilla, whereby the selective action
of one ER (ERb) can be differentially promoted, along
with upregulation of (estrogen-generating) aromatase activity.
On the one hand, this adds to the complexity of andro-
gen-independent endocrine controls of hair growth. On the
other hand, this amply documents that the time has come to
look well beyond the ‘‘androgen horizon’’ when investigating
the endocrine controls of hair growth by sex steroids – and
when exploring how these may be exploited in future,
innovative ‘‘hormonal’’ therapy of common hair growth
disorders.
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CONCLUSION
The HF ranks among the most exciting current research frontiers
in skin, hair, and stress biology and, in cutaneous neuroimmu-
nology and neuroendocrinology. The elusive intrafollicular bio-
logical clock mechanism that regulates hair follicle cycling may
well be influenced by local neuroendocrine, stress-modulated
events that ultimately result in defined switches of the intra-
and perifollicular-signaling milieu of important growth factors.
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